Abdominal SCIEX.

.. Abdominal SCIEX, Prosolia enter technology license agreement Prosolia, Inc. And AB SCIEX announced today that they have entered right into a license contract for technologies developed by Dr. Gary Van Berkel and his colleagues of Oak Ridge National Laboratory . Van Berkel can be an innovator in neuro-scientific mass spectrometry and may be the recipient of many awards for his contributions in the field. Related StoriesThermo Scientific Scientific launches HyPerforma SUM DS 300 system for multiple usesThermo Fisher Scientific launches Brilliance GBS AgarNew pre-validated fluorinated fragment library boosts medication screening efficiency Our contract with AB SCIEX further strengthens our placement as the leader in ambient ionization mass spectrometry systems, stated Justin Wiseman, President and CEO of Prosolia.In a evaluation of recurrent diarrhea with or without laboratory confirmation of C. Difficile infection and with or without antibiotic treatment for C. Difficile an infection, 28 percent of patients in the antibody group experienced recurrent diarrhea, as compared with 50 percent of those in the placebo group . Difficile infection differed considerably between your two study groupings .). The relative risk of recurrence based on total times of follow-up for every study group was significantly low in the antibody group . Severe diarrhea was defined as at least five unformed stools each day for at least 2 consecutive days, you start with the stool counts documented on day 1 through cessation of diarrhea and discontinuation of antibiotic treatment for the initial episode.